⚫︎TTM-002: Therapeutic agent for tauopathy: Basic research phase after compound selection

⚫︎TTM-001: Familial Alzheimer’s Disease: Investigator-Initiated Clinical Trial (Phase I/II)

⚫︎Sporadic Alzheimer’s Disease: Preclinical Research (compound selection)